Ion channels may be the Achilles’ heel of the SARS-CoV-2 virus, with research emerging from Israel that identified eight already-approved compounds that inhibit the activity of the E-protein channels in the virus’ membrane.
Health officials are looking into Canadian data that suggests the risk of heart inflammation after Moderna’s Covid-19 shot is occurring at higher rates in younger adults than previously believed.
The UK drug regulator approved an antibody cocktail developed by Regeneron and Roche to prevent and treat Covid-19, as the nation battles rising hospitalizations due to the more infectious Delta variant.
As the work force returns to the office, life science companies are having to take their stance on vaccine policy. Some have chosen a strict mandate, others a mandate with options, and others have yet to issue an edict.
U.S. states are racing to meet a deadline to commit to a $26 billion opioid settlement with three drug distributors and the drugmaker Johnson & Johnson, as some grapple with local resistance and concerns the amount is not large enough to address the damage done by an epidemic of addiction.
A British public health study found that protection from either of the two most commonly used Covid-19 vaccines against the prevalent Delta variant of the coronavirus weakens within three months.
Florida’s largest school district on Aug. 18 imposed a mask mandate in defiance of the state’s governor, another chapter in the coronavirus political battle in the southern United States where new infections are highest.
The Covid-19 vaccines available in the United States are still highly effective at preventing hospitalization but their effectiveness against new infections has decreased as the Delta variant spread, according to new studies published on Aug. 18 in Morbidity and Mortality Weekly Report. A different study suggests children’s noses may be better than adults’ at defending against infection because of “pre-activated” immunity against the coronavirus.
Google’s Verily snapped up Raleigh, N.C.-based SignalPath and the company’s clinical trial management system that is expected to support its own clinical trial and evidence-based platform known as Baseline.
The United States reported more than 1,000 Covid-19 deaths on Aug. 17 – equating to around 42 fatalities an hour – according to a Reuters tally, as the Delta variant continues to ravage parts of the country with low vaccination rates.
